14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ARIA
Delisted

ARIAD Pharmaceuticals Fund Forecast

$23.99
+0 (+0%)
At Close: Mar 13, 2017
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

ARIAD Pharmaceuticals fund price down 0% on Monday
(Updated on Mar 13, 2017)

Hold candidate since Feb 27, 2017 PDF

No changes to the price of ARIAD Pharmaceuticals fund on the last trading day (Monday, 13th Mar 2017). During the last trading day the fund fluctuated 0% from a day low at $23.99 to a day high of $23.99. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The fund lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $22.79 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the fund is expected to rise 66.42% during the next 3 months and, with a 90% probability hold a price between $37.93 and $55.73 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ARIA Signals & Forecast

The ARIAD Pharmaceuticals fund holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $23.99 and $23.89. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, January 26, 2017, and so far it has risen 1.48%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. The fund had a Golden Star Signal on Monday, July 18, 2016 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the fund in question.

Support, Risk & Stop-loss for ARIAD Pharmaceuticals fund

ARIAD Pharmaceuticals finds support from accumulated volume at $23.75 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the fund tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the fund During the last day, the fund moved $0 between high and low, or 0%. For the last week the fund has had daily average volatility of 0%

Our recommended stop-loss: $22.63 (-5.67%) (This fund has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 31 days ago.)

Trading Expectations (ARIA) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect ARIAD Pharmaceuticals to open at $23.99, and during the day (based on 14 day Average True Range), to move between $23.93 and $24.05, which gives a possible trading interval of +/-$0.0626 (+/-0.26%) up or down from last closing price. If ARIAD Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 0.52% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $23.75, some $0.240 (1.00%) from the current price of $23.99, our system finds the risk reward attractive.

Is ARIAD Pharmaceuticals fund A Buy?

ARIAD Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.750 Hold/Accumulate Unchanged

Predicted Opening Price for ARIAD Pharmaceuticals of Tuesday, March 14, 2017

Fair opening price March 14, 2017 Current price
$23.99 ( 0%) $23.99

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ARIA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 23.99 .
R2 23.99 .
R1 23.99 .
Current price: 23.99
Support S1 23.99 .
S2 23.99 .
S3 23.99 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 23.99
Support S1 23.75 -1.00%
S2 23.70 -1.21%
S3 23.68 -1.29%

FAQ

What is the symbol for ARIAD Pharmaceuticals Fund and on which exchange is it traded?
The symbol for ARIAD Pharmaceuticals is ARIA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ARIAD Pharmaceuticals Fund?
ARIAD Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy ARIAD Pharmaceuticals Fund?
ARIAD Pharmaceuticals Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ARIAD Pharmaceuticals Fund.

What's the current price of ARIAD Pharmaceuticals Fund?
As of the end of day on the Mar 13, 2017, the price of an ARIAD Pharmaceuticals (ARIA) share was $23.99.

What is the 52-week high and low for ARIAD Pharmaceuticals Fund?
The 52-week high for ARIAD Pharmaceuticals Fund is $23.99 and the 52-week low is $6.02.
Click to get the best stock tips daily for free!

About ARIAD Pharmaceuticals

ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of drugs for cancer patients in the United States and internationally. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult patients with chronic myeloid leukemia (CML), and Philadelphia chromosome-positive acute lymphoblastic leukemia in the United States, the European Union, Australia, Switzerland... ARIA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT